The satellite imagery analytics company has raised money from a consortium that included existing client Cargill.

CureFit Healthcare has raised funding from investors including the UC-RNT fund, a venture capital vehicle established by University of California with Ratan Tata.

Bertelsmann Asia Investments has returned to back a $34m series C round for Treebo Hotels, having previously led a $16.6m series B just over a year ago.

CSL Behring has agreed to acquire Calimmune, a developer of gene therapy treatments that is backed by an unnamed pharmaceutical firm.

Legend Capital has celebrated an exit as Berry Genomics completed a reverse merger with Chengdu Tianxing Instrument and Meter in a deal worth $653m.

Alibaba-backed Best hopes to raise $1bn in a flotation on the New York Stock Exchange.

Boston Scientific, Medtronic and GlaxoSmithKline returned to support a $30m series D round for biomedical technology company SetPoint Medical.

Qianhai Xino-backed Akeso Biopharma will use the series B capital to build a drug manufacturing facility in China.